Sutro Biopharma: A Risky Long on ADC Momentum and Fresh Runway
Sutro Biopharma (STRO) is trading near its 52-week high after a financing and early-stage ADC progress. The trade idea is a cautious long: entry $24.50, target $32.00, stop $18.00, horizon 180 trading days. The thesis rests on momentum into multiple ADC programs and cleaner balance-sheet runway; the counterpoint is steep clinical and cash-flow risk…